Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes.
Ting DSW, Cheung CY, Lim G, Tan GSW, Quang ND, Gan A, Hamzah H, Garcia-Franco R, San Yeo IY, Lee SY, Wong EYM, Sabanayagam C, Baskaran M, Ibrahim F, Tan NC, Finkelstein EA, Lamoureux EL, Wong IY, Bressler NM, Sivaprasad S, Varma R, Jonas JB, He MG, Cheng CY, Cheung GCM, Aung T, Hsu W, Lee ML, Wong TY.
JAMA. 2017 Dec 12;318(22):2211-2223. doi: 10.1001/jama.2017.18152.
PMID:29234807
Association between Glucagon-like Peptide-1 Receptor Agonists and the Risk of Glaucoma in Individuals with Type 2 Diabetes.
Niazi S, Gnesin F, Thein AS, Andreasen JR, Horwitz A, Mouhammad ZA, Jawad BN, Niazi Z, Pourhadi N, Zareini B, Meaidi A, Torp-Pedersen C, Kolko M.
Ophthalmology. 2024 Sep;131(9):1056-1063. doi: 10.1016/j.ophtha.2024.03.004. Epub 2024 Mar 13.
PMID:38490274
Neuroprotective Effects of Anti-diabetic Drugs in the Treatment of Patients with Diabetes and Glaucoma or at High Risk for Glaucoma.